SEC 13F Intelligence

Alpine Global Management, LLC / IMVT

Alpine Global Management, LLC’s Immunovant Inc Position

Does Alpine Global Management, LLC own Immunovant Inc (IMVT)? Yes — 2.64M shares worth $66M (+9.81% of its 13F portfolio) as of Q1 2026, up from 2.63M shares the prior filed quarter.

Position Value
$66M
Q1 2026
Shares
2.64M
% of Portfolio
+9.81%
Quarters Held
21
currently held

Position History IMVT

Reported value by quarter
Q1 ’21: $18MQ1 ’21Q2 ’21: $21MQ3 ’21: $26MQ4 ’21: $26MQ4 ’21Q1 ’22: $43MQ2 ’22: $17MQ3 ’22: $24MQ3 ’22Q4 ’22: $26,625Q1 ’23: $22,327Q2 ’23: $27,308Q2 ’23Q3 ’23: $48MQ4 ’23: $59MQ1 ’24: $61MQ1 ’24Q2 ’24: $50MQ3 ’24: $54MQ4 ’24: $107MQ4 ’24Q1 ’25: $45MQ2 ’25: $42MQ3 ’25: $44MQ3 ’25Q4 ’25: $67MQ1 ’26: $66Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.64M$66M+9.81%
Q4 20252.63M$67M+14.39%
Q3 20252.75M$44M+9.00%
Q2 20252.63M$42M+9.47%
Q1 20252.63M$45M+11.88%
Q4 20244.32M$107M+13.99%
Q3 20241.88M$54M+12.99%
Q2 20241.91M$50M+8.76%
Q1 20241.88M$61M+15.29%
Q4 20231.40M$59M+18.84%
Q3 20231.25M$48M+12.15%
Q2 20231.44M$27,308+8.29%
Q1 20231.44M$22,327+8.67%
Q4 20221.50M$26,625+8.85%
Q3 20224.35M$24M+5.68%
Q2 20224.45M$17M+4.97%
Q1 20227.72M$43M+5.29%
Q4 20213.01M$26M+3.77%
Q3 20213.00M$26M+5.92%
Q2 20212.00M$21M+2.88%
Q1 20211.10M$18M+1.69%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Alpine Global Management, LLC’s full portfolio or all institutional holders of IMVT.